EN
HI

LINCOLN PHARMA Share price

LINCOLN

HealthcareSmall

573

15.90 (2.85%)
NSE
BSE
Last updated on 12 May, 2025 | 15:29 IST
BUYSELL
Today's High

563.20

Today's Low

574.80

52 Week Low

979.50

52 Week High

979.50

The current prices are delayed, login to your account for live prices

Lincoln Pharmaceuticals Chart

LINCOLN PHARMA Share Key Metrics

Volume
29103.00
Market Cap
1115.86 CR
LTQ@LTP
3@573.00
ATP
569.25
Var Margin
2224
Circuit Range
445.7-668.5
Delivery %
43.2
Value
1.66 CR
ASM/GSM
No
Market Lot
1

LINCOLN PHARMA Futures & Options

Data Not Found

LINCOLN PHARMA Corporate Actions

DateAgenda
2025-02-13Quarterly Results
DateEvent TypeAgenda
2025-02-13Board MeetingQuarterly Results

LINCOLN PHARMA News

Lincoln Pharmaceuticals Ltd enters elite league; Enters Rs. 1,000 crore plus market cap club

Aug 29 2023 17:37:24
Read More

About LINCOLN PHARMA

NSE : 11596  
BSE : 531633  
ISIN : INE405C01035  

The Company was incorporated as a public limited company by converting partnership concern M/s. Lincoln Pharmaceuticals under Part IX of the Companies Act 1956. M/s.Lincoln Pharmaceuticals was established as a partnership firm on 18th January 1979 with Mr. Rajni G. Patel Mr. Hasmukhbhai I.Patel Mrs. Hansaben A.Patel Mrs. Jivtiben C.Patel Mrs.Jiviben T.Patel and Mrs. Lilaben T. Patel as partners with its main object of manufacturing pharmaceutical formulations. The business was started in Naroda G.I.D.C estate. Further on 9.12.81 Mr.Mihir V. Patel Mr.Maheshbhai M.Patel Mr.Yogeshkumar I. Patel and Mrs.Madhuben V.Patel were admitted as Partners. The firm was carrying on its business by getting its products manufactured on Loan and Licence Basis from 1979 to 1982.All the partners decided and agreed vide resolution dated 30.10.94 that all members of Co-partnership should register the said firm as public limited company for sake of smooth working better and effective management and improvement and advancement of business. It was also decided as per the said resolution that such company should carry Out and continue the existing business of the firm. As a result anthe incorporation of the Company on 20th January 1995 all the properties of the firm (movable & immovable) and all the liabilities of the firm 55 an the closing of the business of the day proceeding the date of incorporation of the Company vested in the Company. Since date of incorporation of the Company i.e 20th January 1995 all the assets and liabilities aforesaid as on 19th January 1995 vested in the Company. Company is carrying on running business of erstwhile M/s. Lincoln Pharmaceuticals having its formulations production facilities at Naroda GIDC Ahmedabad Gujarat of manufacturing tablets capsules liquid and powder syrups and ointments. Company is alsogetting its products manufactured on "Loan and License" basis from other manufacturers to meet the demand of small volume parenterals.The Company has now decided to establish modern formulations manufacturing plant at Village: Khatraj. Tal:Kalol Olaf. Mehsana in Gujarat to manufacture small volume parenterals like Dry powder injectables liquid vial liquid ampoules and eye drops and expand itsproduction capacities of manufacturing tablets capsules liquid/powder syrups and ointment and also to establish fully equipped laboratory to undertake in house testing of its products for better quality control and give thrust on Research and Development. Company has already acquired N.A land Adm: 8833 Sq. Mtrs. and is in the process of acquiring further land adm. aprox.11170 Sq.Mtrs. Company has givenadvance for booking cement and steel and are preparing to commence construction of factory building at new site. Company has identified all plant and machineries and has also given advance to major plant & machinery suppliers far those machineries which has longer delivery period so as to implement the project an time. The company has existing manufacturing facilities at Naroda and if is alreadyselling its products all over India and is having thrust in the markets of Gujarat Rajasthan Andhra Pradesh Bihar and Jammu.

LINCOLN PHARMA Management

NamePosition
Mr. Kishor M Shah Non Executive Chairman
Mr. Mahendra G Patel Managing Director
Mr. Hashmukh I Patel Whole Time Director
Mr. Munjal M Patel Whole Time Director
Mr. Ashish R Patel Whole Time Director
Read More

LINCOLN PHARMA FAQs

The Buying Price of LINCOLN PHARMA share is 348.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy LINCOLN PHARMA share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of LINCOLN PHARMA shares is 12.48. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio LINCOLN PHARMA shares is 1.69. Useful to assess the stock's value relative to its book value.

To assess LINCOLN PHARMA’s valuation compare Sector P/E, P/B which are 37.31 & 4.59 with sector averages, along with growth rates and financial metrics.

The Market Cap of LINCOLN PHARMA is 1115.86 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of LINCOLN PHARMA share price is 979.50 & 499.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.